# E-DRUG: International Society for Pharmacoepidemiology **URL:** \ **Category:** e-drug\ **Created:** [February 23, 1998, 7:32pm UTC](https://talk.edrugplus.org/t/e-drug-international-society-for-pharmacoepidemiology/2168 "1998-02-23T19:32:46Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Alec\_Walker](https://avatars.discourse-cdn.com/v4/letter/a/4bbf92/32.png) [@Alec\_Walker](https://talk.edrugplus.org/u/Alec_Walker)\ **Post date:** [February 23, 1998, 7:32pm UTC](https://talk.edrugplus.org/t/e-drug-international-society-for-pharmacoepidemiology/2168/1 "1998-02-23T19:32:46Z")
E-drug: International Society for Pharmacoepidemiology ------------------------------------------------------- Dear Fellow E-Druggers: This is a call to those of you who are also members of the International Society for Pharmacoepidemiology (ISPE). I have been asked to edit the reborn newsletter for ISPE, to be called Scribe. As you are aware, essential drugs are a small part of the world of most ISPE members. Our membership profile is dominated by regulators, industry medical affairs personnel, and academics concerned with drug safety and utilization. Not by intent, but by demographics, almost all of the professional focus of ISPE is on the Europe-North America-Japan axis. I would like to assist the elements within the Society that have a different global perspective. If there are issues that arise on E-DRUG list, or other points that you think you might wish to address in a 300-500 essay aimed at the ISPE membership, I would be really grateful to hear about it. The topic should be of current interest, and the essay should be informational rather than polemical. (This is not to say that you can't express an opinion. There should be a preponderance of fact, to allow the reader to form an opinion as well.) Thank you in advance, Alec Alexander M. Walker Department of Epidemiology Harvard School of Public Health Boston MA 02115 tel +1 617 432 4565 fax +1 617 566 7805 e-mail: amwalker@episun1.harvard.edu -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.